東瑞製藥(02348.HK)與南京漢欣訂立產品合作協議
格隆匯9月23日丨東瑞製藥(02348.HK)發佈公吿,公司全資附屬公司蘇州東瑞製藥已與獨立第三方南京漢欣醫藥科技有限公司(“南京漢欣”)訂立產品合作協議聯合進行下列產品的研發,並協助蘇州東瑞製藥成為該等產品的上市許可持有人(MAH):
(a)Z2101和Z2102--Z2101是一次性注射用預灌封注射劑,Z2102是安培瓶注射劑。這兩種藥物均用於血液和造血系統以預防和治療出血。
(b)Z2103--它是一種合成多肽激素,甲狀旁腺激素(PTH)的1-34氨基酸片段,以多劑量預灌封注射筆包裝,用於治療骨質疏鬆症的注射劑。
(c)H2104和Z2105--一種原料藥及以多劑量預灌封注射筆包裝,用於輔助生殖的注射劑。它是一種人工合成的多肽激素,屬於促性腺激素釋放激素(GnRH)拮抗劑。
(d)Z2106--它是一種合成長效胰高血糖素樣肽-1(GLP-1)類似物,以多劑量預灌封注射筆包裝,用於治療糖尿病的注射劑。
隨着中國人口老齡化,預計對於糖尿病和骨質疏鬆症等慢性病的治療需求,包括高質量、安全、患者自行注射的注射劑的需求將有所增加。與南京漢欣合作,集團可針對糖尿病及骨質疏鬆症等領域開發一系列使用注射筆作為給藥系統的多肽治療劑,長遠而言可提升集團的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.